Early Morbidity and Mortality in Patients Undergoing Radical Gastrectomy and Bursectomy in Gastric Cancer
PDF
Cite
Share
Request
Research
VOLUME: 14 ISSUE: 4
P: 398 - 402
December 2018

Early Morbidity and Mortality in Patients Undergoing Radical Gastrectomy and Bursectomy in Gastric Cancer

Med J Bakirkoy 2018;14(4):398-402
1. İstanbul Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 12.04.2018
Accepted Date: 09.06.2018
Publish Date: 28.12.2018
PDF
Cite
Share
Request

ABSTRACT

Objective:

Our objective in this study is to compare the preoperative parameters and postoperative early results of patients with gastric adenocarcinoma who were treated with radical gastrectomy and regional lymph node dissection technique and who underwent bursectomy additional to this technique.

Materials and Methods:

A total of 50 patients with gastric adenocarcinoma who underwent radical gastrectomy + D2 dissection (A) and radical gastrectomy + D2 dissection + bursectomy (B) in our clinic between January 2010 and January 2013 were evaluated retrospectively. Patients who underwent A and B surgeries were compared for their demographic characteristics, tumor histopathologies, perioperative status and postoperative complications within the first 30 days.

Results:

When demographic characteristics and tumor histopathologies of the patients were compared, no statistically significant difference was found between the 2 groups. When the patints’ perioperative status and postoperative complications within the first 30 days were compared, pancreatic leakage and pulmonary effusion were observed more frequently in the group with bursectomy; but the differences between the 2 groups were not statistically significant.

Conclusion:

By comparing the early results in our study, no differences were demonstrated in 2 groups in terms of complications and benefits. It is concluded that there is a need to evaluate the benefits and harms of bursectomy with more preoperative stating data and postoperative longer follow-up.

Keywords:
Gastric cancer, bursectomy, postoperative complication

References

1
T.C. Sağlık BakanlığıKanserle Savaş Derneği 2002
2
Jeung HC, Rha SY, Noh SH, Min JS, Kim BS, Chung HC. Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. Cancer 2001;91:2016-25.       
3
Parkin DM. International variation. Oncogene 2004;23:6329-40.
4
Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9.
5
Fujita J, Kurokawa Y, Sugimoto T, Miyashiro I, Iijima S, Kimura Y, et al. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer 2012;15:42-8.
6
Imamura H, Kurokawa Y, Kawada J, Tsujinaka T, Takiguchi S, Fujiwara Y, et al. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg 2011;35:625-30.
7
Eom BW, Joo J, Kim YW, Bae JM, Park KB, Lee JH, et al. Role of bursectomy for advanced gastric cancer: result of a case–control study from a large volume hospital. Eur J Surg Oncol 2013;39:1407–14.
8
Kochi M, Fujii M, Kanamori N, Kaiga T, Mihara Y, Funada T, et al. D2 gastrectomy with versus without bursectomy for gastric cancer. Am J Clin Oncol 2014;37:222-6.
9
Shen WS, Xi HQ, Wei B, Chen L. Effect of gastrectomy with bursectomy on prognosis of gastric cancer: a meta-analysis. World J Gastroenterol 2014;20:14986-91.
10
Zhang WH, Chen XZ, Yang K1, Liu K, Chen ZX, Zhang B, et al. Bursectomy and non bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China. World J Surg Oncol 2015;13:332.
11
Herbella FA, Tineli AC, Wilson Jr JL, Del Grande JC. Gastrectomy and lymphadenectomy for gastric cancer: is the pancreas safe? J Gastrointest Surg 2008;12:1912-4.
12
Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005;23:7114-24.
13
Giuliani A, Caporale A, Corona M, Di Bari M, Demoro M, Ricciardulli T, et al. Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count. J Exp Clin Cancer Res 2004;23:215-24.
14
Shen JY, Kim S, Cheong JH, Kim YI, Hyung WJ, Choi WH, et al. The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer 2007;110:745-51.
15
Chen XZ, Yang K, Zhang B, Hu JK, Zhou C. Is retrieval of >25 lymph nodes a superior criterion for locally advanced gastric cancer surgery? Ann Surg 2011;254:834-5.
16
Siewert JR, Böttcher K, Stein HJ, Roder JD .Relevant prognostic factors in gastric cancer: ten -year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-61.
17
Wei-Song Shen, Hong-Qing Xi, Bo Wei, Lin Chen. Effect of gastrectomy with bursectomy on prognosis of gastric cancer: A meta-analysis. World J Gastroenterol 2014;20:14986-91.